Dmitri Boudko

Title: Dmitri Boudko: Innovator in Polynucleotide Compositions

Introduction

Dmitri Boudko is a notable inventor based in Menlo Park, CA. He has made significant contributions to the field of biotechnology, particularly in the development of polynucleotide compositions. His work focuses on innovative methods for treating conditions associated with cystic fibrosis.

Latest Patents

Dmitri Boudko holds a patent for "Polynucleotide compositions, related formulations, and methods of use thereof." This patent discloses compositions of polynucleotide(s) and pharmaceutical formulations that may encode for a cystic fibrosis transmembrane conductance regulator (CFTR) protein or a functional fragment thereof. The polynucleotide can be assembled with a lipid composition for targeted delivery to specific cells or organs, such as lung cells. Additionally, the patent outlines methods for enhancing the expression or activity of CFTR protein in cells and for treating subjects with CFTR-associated conditions. He has 1 patent to his name.

Career Highlights

Dmitri Boudko is currently associated with Recode Therapeutics, Inc., where he continues to advance his research in biotechnology. His innovative approaches have the potential to significantly impact the treatment of genetic disorders.

Collaborations

Dmitri has collaborated with notable colleagues, including Mirko Hennig and Daniella Ishimaru, to further his research and development efforts in the field.

Conclusion

Dmitri Boudko's work in polynucleotide compositions represents a significant advancement in biotechnology, particularly for cystic fibrosis treatment. His contributions are paving the way for innovative therapeutic solutions.